跳至主要内容
临床试验/CTRI/2024/08/071861
CTRI/2024/08/071861尚未招募Unknown

Impact of Multiple Micronutrients Fortified Oral Nutrition Supplements on Physical Growth, Muscle Parameters, Strength, and Cognitive Development in School Aged Children (6-16 years): Randomized Controlled Comparative Study - NI

Hindustan Unilever Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Normal and mildly malnourished children with BMI-for-age percentiles [between 3rd to 25th percentile (-1.881) to (-0.674) z-score] by calculating as per WHO 5-19 years Growth Reference will be included
  • 2.Screening for anemia will be done to include all children with hemoglobin =8 mg/dl
  • 3.Children = 6 years to = 16 years will be included. (25-30 children per age). Stratification of pubertal (10 -15+ years) and prepubertal (6-9+ years) will be done later. Both boys and girls will be included
  • 4.Children should not be lactose intolerant /have lactose sensitivity and be comfortable to have milk daily.
  • [0 – (-1 SD) are normal children; (-1 to -1.9 SD) is defined as mild malnutrition; [-2 to -2.9 SD) is defined as moderate malnutrition; [(= -3) is defined as severe malnutrition].
  • [mild anaemia defined as 11 – 11.49 and 11 – 11.99 mg/dl for children 5-11 years and 12-14 years respectively; moderate anaemia defined as 8 - 10.99 mg/dl for children 5-11 years and 12-14 years respectively]

排除标准

  • Children will be excluded at the time of screening, if they had been diagnosed or were known to:
  • 1.be lactose intolerant and galactosaemic
  • 2.be allergic or intolerant to wheat / any other cereal
  • 3.have a current acute or chronic infection including but not restricted to respiratory infection, diarrhoea, Hepatitis B or C, HIV infection or tuberculosis.
  • 4.have severe gastrointestinal disorders including celiac disease, short bowel syndrome, pancreatic insufficiency, or cystic fibrosis; have a diagnosis of neoplastic, renal, hepatic or cardiovascular disease, hormonal or metabolic disorders, congenital disease or genetic disorders such as atrial or ventricular wall defects, or Down’s syndrome, infantile anorexia nervosa, developmental disability, including physical disorders such as cerebral palsy, or developmental delay.
  • 5.diagnosed with disorders of haemoglobin structure, function, or synthesis according to medical records or parent/guardian report, or
  • 6.have been diagnose with ADHD, any form of delayed / impaired cognitive development, delayed developmental milestones, or is on any form of medication for other cognitive conditions.
  • 7.have had a clinically significant nutritional deficiency requiring specific treatment with another similar nutritional supplement (other than the study product) or
  • 8.have any other clinically significant medical condition, which, in the investigator’s opinion, made the child unsuitable for inclusion in the study.

研究者

相似试验